Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05521711 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

TRADE Trial - Tree Nut Immunotherapy Route Development and Evaluation

Study acronym: TRADE
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Nov 1, 2022 to Sep 1, 2023
    • Study sites: 0 to 1
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Tree nut immunotherapy Route Assessment and DEvelopment (TRADE) is a randomized controlled trial that evaluates the efficacy and safety of sublingual immunotherapy and lower, more tolerable, doses of oral immunotherapy than currently in use.
Trial Details
NCT Number NCT05521711
Lead Sponsor Hamilton Health Sciences Corporation
Collaborators: AAAAI Foundation
Conditions
(from sponsor)		 Tree Nut Allergy, Food Allergy
Related terms Food Hypersensitivity, Nut Hypersensitivity
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov